Pharmacogenomics in the age of personalized medicine
- 1 September 2016
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Technologies
- Vol. 21-22, 11-16
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsClinical Pharmacology & Therapeutics, 2015
- Pharmacogenomic information in drug labels: European Medicines Agency perspectiveThe Pharmacogenomics Journal, 2015
- CYP2D6 and Pharmacogenomics: Where Does Future Research Need to Focus? Part 1: Technical AspectsPharmacogenomics, 2014
- Pharmacogenetics: past, present and futureDrug Discovery Today, 2011
- Complement in age-related macular degeneration: a focus on functionEye, 2011
- Designing Pharmacogenomic Studies to be Fit for PurposePharmacogenomics, 2010
- Pharmacogenetics and pharmacogenomicsBritish Journal of Clinical Pharmacology, 2001
- Genetic Risk of Age-related MaculopathyArchives of Ophthalmology (1950), 1998
- A Twin Study of Age-related Macular DegenerationAmerican Journal of Ophthalmology, 1995
- Sibling correlations and segregation analysis of age‐related maculopathy: The beaver dam eye studyGenetic Epidemiology, 1994